CVS Caremark (CVS) Scheduled to Post Quarterly Earnings on Tuesday
CVS Caremark (NYSE:CVS) will be announcing its Q214 earnings results on Tuesday, August 5th. Analysts expect the company to announce earnings of $1.10 per share and revenue of $33.47 billion for the quarter.
CVS Caremark (NYSE:CVS) opened at 76.49 on Monday. CVS Caremark has a 52-week low of $56.32 and a 52-week high of $79.43. The stock’s 50-day moving average is $76.84 and its 200-day moving average is $74.01. The company has a market cap of $89.723 billion and a P/E ratio of 19.48.
A number of analysts have recently weighed in on CVS shares. Analysts at Susquehanna raised their price target on shares of CVS Caremark from $85.00 to $90.00 in a research note on Friday, June 6th. They now have a “positive” rating on the stock. On the ratings front, analysts at Zacks reiterated a “neutral” rating on shares of CVS Caremark in a research note on Thursday, May 29th. They now have a $81.00 price target on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of CVS Caremark from $80.00 to $83.00 in a research note on Wednesday, May 28th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $77.63.
In other CVS Caremark news, SVP Eva C. Boratto sold 22,107 shares of the company’s stock on the open market in a transaction that occurred on Monday, July 21st. The stock was sold at an average price of $76.77, for a total transaction of $1,697,154.39. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.